SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is trending as the community debates a perplexing post-earnings sell-off despite reporting a strong beat and raised guidance, with many perceiving it as an algorithmic-driven buying opportunity amidst volatile software sector sentiment.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as its oral VK2735 obesity drug is advancing directly into Phase 3, which the community views as strong FDA validation for a potential breakthrough in the competitive GLP-1 market. Many are also discussing a potential short squeeze and buyout possibilities, especially as regulators crack down on unapproved weight-loss compounds.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is a focal point of discussion following the inauguration of its Eagle Line pilot production facility, with the community eagerly anticipating the upcoming earnings report for updates on scaling its solid-state battery technology and potential OEM customer partnerships, amidst persistent debate over commercialization timelines and market volatility.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management system, as well as other tools, integrations and native payment solutions. It operates through the following geographical segments: Americas, Europe and Asia Pacific. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is trending after reporting strong earnings, raising its outlook, and announcing a $1 billion share repurchase program, yet the stock experienced a significant drop, fueling investor frustration and a community debate over whether "AI fears" are unfairly impacting SaaS valuations.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is trending following an earnings beat and raised guidance, fueled by robust demand for AI infrastructure, prompting community discussion around the stock nearing its dot-com era highs and its valuation in the current tech cycle.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is trending after reporting robust Q4 earnings, strong Q1 revenue guidance, and authorizing a $2 billion share buyback program. Despite initial pre-market optimism, the stock faced a sharp market open sell-off, prompting widespread community discussion around "manipulation" and creating a "buy the dip" opportunity for long-term growth and its AI commerce vision.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly Inc is trending following a significant beat on its Q4 earnings and robust FY26 guidance, signaling a potential turnaround driven by new leadership and increasing tailwinds from AI adoption in edge computing and security. The community is actively discussing this as an inflection point, with many long-term holders finally seeing a promising path forward for the company's growth.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending due to its deep involvement in the broader software sector's intense sell-off, where market fears about AI disruption are driving widespread panic and pushing many SaaS stocks, including CRM, to multi-year lows. While a segment of the community views this as an illogical overreaction and a generational buying opportunity, emphasizing CRM's strong fundamentals and AI integration, the prevailing sentiment remains one of extreme caution.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending following a strong Q4 earnings report that exceeded expectations, driven by successful global comparable sales and its value leadership strategy. The community is actively discussing how this performance highlights the "K-shaped economy," where consumers are increasingly opting for affordable fast food over pricier alternatives, alongside a dividend increase.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Its imminent merger with Infleqtion and upcoming NYSE listing under the INFQ ticker are driving conversation for Churchill Capital Corp X, fueled by recent announcements of Infleqtion's quantum technology being selected for a NASA space mission and a DOE energy grid contract. The community widely views Infleqtion as a highly promising and undervalued leader in the quantum sector, anticipating significant upside post-merger compared to its peers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Rating of "Buy" from Brokerages

Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) has earned an average recommendation of "Buy" from the nine research firms that are presently covering the firm, MarketBeat.com reports. One...

Foghorn Therapeutics (NASDAQ:FHTX) Shares Down 4.1% - Time to Sell?

Foghorn Therapeutics (NASDAQ:FHTX) Shares Down 4.1% - Here's Why...

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff PR Newswire VANCOUVER, BC, Jan...

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) have been given a consensus recommendation of "Buy" by the nine research firms that are currently covering the company...

Wall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to "Buy"

Wall Street Zen raised shares of Foghorn Therapeutics from a "hold" rating to a "buy" rating in a research note on Saturday...

BTIG Research Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to Strong-Buy

BTIG Research raised shares of Foghorn Therapeutics to a "strong-buy" rating in a report on Thursday...

3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment

J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.

Platform Technologies Drive $211B Surge in Precision Cancer Treatment

Platform Technologies Drive $211B Surge in Precision Cancer Treatment Platform Technologies Drive $211B Surge in Precision Cancer Treatment PR Newswire VANCOUVER, BC, Dec. 11, 2025 Issued on behalf...

Foghorn Therapeutics (NASDAQ:FHTX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut Foghorn Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of "Buy" from Analysts

Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX - Get Free Report) have received a consensus recommendation of "Buy" from the eight brokerages that are presently covering the company, MarketBeat...

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Foghorn Therapeutics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $COIN earnings on Thursday?

Current Price	$5.42
Prev Close	$5.45
Open	$5.53
Dividend Yield	0.00%
50-Day Moving Average	$5.30
Beta	1.76
Avg. Volume	199,582.30
PE Ratio	-4.59

52-Week High	$6.95
52-Week Low	$2.94
Market Capitalization	$319.27M
EPS (Annual)	-$1.58
Price to Book	-3.44
Revenue Per Employee	$201,803.57

FHTX
Foghorn Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest FHTX News

FHTXFoghorn Therapeutics Inc